Home

Mesothelioma

• About Mesothelioma
• Mesothelioma Cause
• Mesothelioma Symptoms
• Mesothelioma Diagnosis
• Mesothelioma Stages

Mesothelioma Treatment

• Treatment Options
• Mesothelioma Surgery
• Mesothelioma Chemotherapy
• Mesothelioma Radiation
• New Approaches
• Palliative Care

Mesothelioma Specialists

• Choosing Your Doctor
• Your Health Care Team
• Cancer Centers

Clinical Trials

• Trial Basics
• Eligibility
• Current Trials

Managing Your Care

• Your Personal Records
• Your Medications
• Your Expenses

Veterans Resources

• Asbestos Disease
• Mesothelioma Detection
• Asbestos Exposure
• Veteran Service Officers

NEWS ABOUT PHARMACEUTICALS IN MESOTHELIOMA TREATMENT

1. Nanoparticles Could Deliver Cancer Drugs
2. Meta-analysis of cancer clinical trials finds 41 percent are superior to existing treatments
3. Vinflunine Shows Promise in Treating Malignant Pleural Mesothelioma
4. Synthetic Molecules Could Offer A Lower Cost Cancer Treatment Alternative
5. "Bacteria Therapy" Shows Promise in Initial Tests
6. New UCLA Machine May Kill Cancer Cells
7. Study raises doubts about some DNA-based drugs
8. Disease-Causing Bugs May Help Treat Cancer
9. New Cancer Vaccine Approved for Limited Use in Russia
10. New Therapy Targets Hepatitis C
11. Innovative New Cancer Treatment Idea Earns $1 Million Prize
12. Higher Doses of Chemotherapy Make No Difference in Small Cell Lung Cancer
13. Nanoparticles Help Advance Anticancer siRNA Therapy
14. Research at MIT Shows microRNA's Protective Role
15. Patients See Benefit From Self Reporting Symptoms Online
16. Cancer drugs from genetically modified chicken eggs
17. Researchers attempting to figure out how cancer grows
18. Antifolates - Chemotherapy drugs
19. Dopamine for cancer treatment
20. Concerns about anemia medications for cancer patients
21. Researchers Developing New Ways of Detecting Cancer
22. Recentin Study Ends
23. Phase II Study of Sutent ® Results Out
24. Terminally Ill Cancer Patients Given Hope in UK
25. New Finding on Correlation Between Angiogenesis, Breast Cancer and Inflammation
26. PET Found to be effective in the Evaluation of Cancer Treatment
27. One-tird of cancer patients experience chronic fatigue after treatment
28. New Drug Cocktails Hold Promise for Cancer, HIV Treatments.
29. New DNA Discovery Changes the Way Doctors Look at Cancer.
30. Inraperitoneal Hyperthermic Chemotherapy for Those Suffering With Abdominal Cancer
31. Mouse Model For Mesothelioma Reproduces Human Disease
32. Researchers Use Transcriptome Analysis by 454 Sequencing to Identify Tumor Specific Mutations Linked to Malignant Pleural Mesothelioma
33. Pre-Clinical Data Show Intracellular Pathways Affected by Onconase
34. Remembering a researcher’s legacy on asbestos research
35. PET proves effective in evaluating cancer treatment
36. Trial on experimental antifolate PDX (Pralatrexate)
37. American College of Physicians releases guidelines for end-of-life care
38. Web-based system helps doctors track outpatients’ chemotherapy toxicity
39. NICE Gives Final Approval for Alimta
40. Par Pharmaceuticals licenses Onconase
41. Thalidomide and Alimta to be Combined in New Clinical Trial
42. Alfacell Updates Status Of ONCONASE(R) Phase III Clinical Program
43. ONCONASE(R) has Potential as Chemopreventive Agent in Mesothelioma
44. Boysenberries might impede mesothelioma
45. Diagnostic Tools For Lung And Mesothelioma Cancers To Be Developed
46. New Mesothelioma Research Center to Open in Sydney
47. Virotherapy to Treat Mesothelioma
48. MIT researchers' "nanocell" delivers a toxic double whammy to tumors
49. FDA Approves the MESOMARK® Assay for the Management of Mesothelioma Patients
50. NYU School of Medicine Verifies Mesothelioma Diagnostic Test
51. Researchers Identify Intracellular Pathway of Alfacell's Onconase
52. New Study
    

    Heralds Shortened Timeline for Anticancer Drug Development

53. Talcum Powder Stunts Tumor Growth
54. Soluble mesothelin in effusions a strong indicator of mesothelioma
55. Diagnostic Tools For Lung And Mesothelioma Cancers To Be Developed
56. New Technology For Cancer Screening Listens For The Signs Of Cancer
57. Onconase(®) is in its final phase 3 trial for treatment of patients with unresectable malignant mesothelioma
58. Data Affirm Benefit of ALIMTA(®) for Patients With Malignant Pleural Mesothelioma
59. New diagnostic tool for mesothelioma to be developed: test will extract microRNAs from a simple blood draw
60. The Barbara Ann Karmanos Cancer Institute announces significant scientific findings related to Malignant Mesothelioma
61. Mild Hyperthermia Enhances Antitumor Effects of Ranpirnase
62. Study shows Mesomark effective for monitoring Mesothelioma
63. FDA Grants Orphan Drug status to Onconase for Mesothelioma
64. Alfacell Corporation Files for U.S. Orphan Drug Designation for Onconase
65. Additional Data From a Phase I Trial of XL647 in Patients With Advanced Solid Tumors
66. New study on the safety, tolerability, pharmacokinetics and preliminary efficacy of INNO-305
67. More evidence that patients treated with Onconase have greater median survival times than patients treated with doxorubicin alone
68. Zolinza becomes first approved HDAC inhibitor
69. Alimta Researchers Recognized As Heroes Of Chemistry
70. Progress on Clinical Development Program for ONCONASE(R) in Malignant Mesothelioma
71. FDA tells Eli Lilly that their Alimta brochure is misleading
72. News about onocology product candidate SS1P (renamed CAT-5001)
73. New Research Shows Unique Promise of Onconase in the Prevention and Treatment of Mesothelioma
74. CuraGen and TopoTarget Announce Initiation of NCI-sponsored Phase II Clinical Trial with PXD101 for Mesothelioma
75. Alfacell Provides Update on ONCONASE Phase IIIb Confirmatory Registration Trial; Releases First Interim Analysis Data
76. Alfacell Achieves Full Patient Enrollment Milestone for the Onconase Phase IIIb Registration Study in Unresectable Malignant Mesothelioma
77. Scientist Reveals His Hopes for Better Tumour Treatment
78. Alfacell Drug Trial Ahead of Schedule
79. Alfacell Forms New Thoracic Cancer Advisory Board
80. Update on Onconase Clinical Program
81. Promising Research in Early Detection of Mesothelioma
82. Morphotek Announces IND Submission for MORAb-009, a Monoclonal Antibody for the Treatment of Mesothelin-Expressing Cancers
83. INNOVIVE Pharmaceuticals Licenses WT1 Peptide Cancer Immunotherapeutic from Memorial Sloan-Kettering Cancer Center
84. Gene Drug Gives Mesothelioma Patient Second Chance
85. Novel therapies for pleural mesothelioma
86. Thoracic Cancer Patients Find New Reasons for Hope with Alimta(®)

Read excerpts from medical publications

Contact Us

**For a FREE information packet including treatments, clinical trials, and specialists, please complete the form above or call a Mesothelioma Web coordinator at 1-877-367-6376.

News

• Mesothelioma News
• International News
• Pharmaceutical News
• Environmental News
• Medical Journal Articles

Resources

• Leading Cancer Links
• Financial Assistance, Compensation, and Legal Rights
• Disclaimer and Sponsorship Information

If you would like to receive a FREE information packet or have questions about mesothelioma, call us at:

Toll-Free 1-877-367-6376